| Anoop Bhatt, MD | |
|
11234 Anderson St # Mc1516, Loma Linda, CA 92354 | |
| (909) 558-4000 | |
| Not Available |
| Full Name | Anoop Bhatt |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 11234 Anderson St # Mc1516, Loma Linda, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255714929 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | ME143271 (Florida) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | A162856 (California) | Primary |
| Entity Name | Veeone Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265156558 PECOS PAC ID: 6800262437 Enrollment ID: O20221021001369 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from a new study in which linagliptin demonstrated statistically significant reductions in blood glucose levels (HbA1c) after 12 weeks (the study's primary endpoint) in adults with type 2 diabetes (T2D) with moderate to severe renal impairment, compared with placebo. Most patients had T2D for more than ten years (76 percent) and were on insulin (86 percent).
Previous evidence, including published National Lung Cancer Screening Trial (NLST) results, shows that computed tomography (CT) lung cancer screening significantly reduces lung cancer deaths in high risk patients*, and is appropriate, with careful patient selection and follow-up.
Outcome Sciences, Inc., the leading provider of patient registries, studies, and technologies for evaluating real-world outcomes, today announced that its TotalQuality Reporting Service has become a certified electronic health records technology reporting module for the Centers for Medicare and Medicaid's Meaningful Use data submission.
Only in Washington could the government raid one entitlement program to finance a brand-new one and still claim that deficits have been reduced and entitlements have been reformed (Rep. Paul Ryan, 8/13).
Octapharma AG is leading an international initiative focused on confronting the major risk associated with hemophilia A therapy - anti-factor VIII (FVIII) antibodies, also known as inhibitors. This initiative, combined with Octapharma's efforts to pursue the first recombinant FVIII therapy produced from a human cell line, could dramatically impact the treatment of an estimated one in every 5,000 to 10,000 men born with hemophilia A worldwide.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anoop Bhatt, MD 11234 Anderson St # Mc1516, Loma Linda, CA 92354-2804 Ph: () - | Anoop Bhatt, MD 11234 Anderson St # Mc1516, Loma Linda, CA 92354 Ph: (909) 558-4000 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from a new study in which linagliptin demonstrated statistically significant reductions in blood glucose levels (HbA1c) after 12 weeks (the study's primary endpoint) in adults with type 2 diabetes (T2D) with moderate to severe renal impairment, compared with placebo. Most patients had T2D for more than ten years (76 percent) and were on insulin (86 percent).
Previous evidence, including published National Lung Cancer Screening Trial (NLST) results, shows that computed tomography (CT) lung cancer screening significantly reduces lung cancer deaths in high risk patients*, and is appropriate, with careful patient selection and follow-up.
Outcome Sciences, Inc., the leading provider of patient registries, studies, and technologies for evaluating real-world outcomes, today announced that its TotalQuality Reporting Service has become a certified electronic health records technology reporting module for the Centers for Medicare and Medicaid's Meaningful Use data submission.
Only in Washington could the government raid one entitlement program to finance a brand-new one and still claim that deficits have been reduced and entitlements have been reformed (Rep. Paul Ryan, 8/13).
Octapharma AG is leading an international initiative focused on confronting the major risk associated with hemophilia A therapy - anti-factor VIII (FVIII) antibodies, also known as inhibitors. This initiative, combined with Octapharma's efforts to pursue the first recombinant FVIII therapy produced from a human cell line, could dramatically impact the treatment of an estimated one in every 5,000 to 10,000 men born with hemophilia A worldwide.
› Verified 5 days ago
Petru Papacostea, Rheumatology Medicare: Medicare Enrolled Practice Location: 11201 Benton St, Loma Linda, CA 92357 Phone: 909-825-7084 | |
Dr. Moosa Azadian, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 11234 Anderson St, Loma Linda, CA 92354 Phone: 909-558-4085 | |
Douglas Wang, Rheumatology Medicare: Medicare Enrolled Practice Location: 11234 Anderson Street, Gme Office Westerly Suite C, Loma Linda, CA 92354 Phone: 909-558-4174 | |
Dr. Lynnetta E Skoretz, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 11201 Benton Street, #111h, Loma Linda, CA 92357 Phone: 909-825-7084 Fax: 909-777-3280 | |
Shahab Sean Shahangian, DO Rheumatology Medicare: Medicare Enrolled Practice Location: 11234 Anderson St, Loma Linda, CA 92354 Phone: 818-532-8211 | |
Mst Nurjahan Khatun, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 11234 Anderson St # C, Loma Linda, CA 92354 Phone: 408-355-8650 | |
Snorri Olafsson, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 11370 Anderson St, Ste 3150, Loma Linda, CA 92354 Phone: 909-558-2191 |